| Lauren Brogis, MD | |
|
700 S Main St, Moscow, ID 83843-3046 | |
| (208) 882-4511 | |
| Not Available |
| Full Name | Lauren Brogis |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 700 S Main St, Moscow, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003267493 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | M-14963 (Idaho) | Primary |
| Entity Name | Public Hospital District #1-a Of Whitman County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366446767 PECOS PAC ID: 8325934987 Enrollment ID: O20040223000506 |
News Archive
WHO will develop, for the first time, a classification of traditional medicine, paving the way for the objective evaluation of its benefits.
The anaesthetic drug Ketamine has been shown to be beneficial in some cases of depression and suicidal ideation which have typically failed to respond to other standard antidepressant medications. A new study has explored the actual workings of ketamine in depression and found that the drug can act on the same receptors as opioid pain relievers.
University of Florida chemists are the first to use a new tool to identify the molecular signatures of serious diseases - without any previous knowledge of what these microscopic signatures or "biomarkers" should look like.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that its lead defensin-mimetic antibiotic compound, PMX-30063, when administered topically as an oral rinse, has shown activity against oral mucositis in an animal study.
› Verified 6 days ago
| Entity Name | Public Hospital District #1-a Of Whitman County |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1366446767 PECOS PAC ID: 8325934987 Enrollment ID: O20070912000859 |
News Archive
WHO will develop, for the first time, a classification of traditional medicine, paving the way for the objective evaluation of its benefits.
The anaesthetic drug Ketamine has been shown to be beneficial in some cases of depression and suicidal ideation which have typically failed to respond to other standard antidepressant medications. A new study has explored the actual workings of ketamine in depression and found that the drug can act on the same receptors as opioid pain relievers.
University of Florida chemists are the first to use a new tool to identify the molecular signatures of serious diseases - without any previous knowledge of what these microscopic signatures or "biomarkers" should look like.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that its lead defensin-mimetic antibiotic compound, PMX-30063, when administered topically as an oral rinse, has shown activity against oral mucositis in an animal study.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Brogis, MD 700 S Main St, Moscow, ID 83843-3046 Ph: (208) 882-4511 | Lauren Brogis, MD 700 S Main St, Moscow, ID 83843-3046 Ph: (208) 882-4511 |
News Archive
WHO will develop, for the first time, a classification of traditional medicine, paving the way for the objective evaluation of its benefits.
The anaesthetic drug Ketamine has been shown to be beneficial in some cases of depression and suicidal ideation which have typically failed to respond to other standard antidepressant medications. A new study has explored the actual workings of ketamine in depression and found that the drug can act on the same receptors as opioid pain relievers.
University of Florida chemists are the first to use a new tool to identify the molecular signatures of serious diseases - without any previous knowledge of what these microscopic signatures or "biomarkers" should look like.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that its lead defensin-mimetic antibiotic compound, PMX-30063, when administered topically as an oral rinse, has shown activity against oral mucositis in an animal study.
› Verified 6 days ago
Dr. Debra K Mckinnon, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Main St, Moscow, ID 83843 Phone: 208-882-4511 Fax: 208-883-6580 | |
Julia Anne Menard, FNP-BC Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 W A St Ste 101, Moscow, ID 83843 Phone: 088-820-5402 | |
Dr. James M Clark, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 700 S Main St, Moscow, ID 83843 Phone: 208-882-4511 | |
Dr. Kurt R Martyn, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 S Main St, Moscow, ID 83843 Phone: 208-882-4511 Fax: 208-883-6580 | |
Victoria Bernard, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 S Washington St, Moscow, ID 83843 Phone: 209-892-1346 | |
William E Caldwell, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 623 S Main St, Moscow, ID 83843 Phone: 208-882-2011 Fax: 208-883-1853 |